US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Dermal Fillers Market Industry Trends and Forecast to 2034: Segmented by (Material, Area, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $3.00 Bn.
Canada at 8.6% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.70 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.79 Bn | — | — |
| 2025 (base) | $3.00 Bn | +$206.4 Mn | — |
| 2026 (forecast) | $3.22 Bn | +$221.6 Mn | +7.4% |
| 2027 (forecast) | $3.45 Bn | +$238.0 Mn | +15.3% |
| 2028 (forecast) | $3.71 Bn | +$255.7 Mn | +23.9% |
| 2029 (forecast) | $3.99 Bn | +$274.6 Mn | +33.1% |
| 2030 (forecast) | $4.28 Bn | +$294.9 Mn | +42.9% |
| 2031 (forecast) | $4.60 Bn | +$316.7 Mn | +53.5% |
| 2032 (forecast) | $4.94 Bn | +$340.2 Mn | +64.8% |
| 2033 (forecast) | $5.30 Bn | +$365.3 Mn | +77% |
| 2034 (forecast) | $5.69 Bn | +$392.4 Mn | +90.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$3.00 Bn
Canada
$554.0 Mn
China
$552.2 Mn
Japan
$455.3 Mn
Germany
$238.7 Mn
France
$187.2 Mn
Brazil
$179.7 Mn
UK
$154.1 Mn
Italy
$139.5 Mn
Spain
$119.3 Mn
Ecuador
$122.1 Mn
India
$113.3 Mn
Saudi Arabia
$109.9 Mn
Mexico
$105.6 Mn
Australia
$86.2 Mn
Russia
$58.7 Mn
New Zealand
$57.0 Mn
South Africa
$44.0 Mn
UAE
$38.0 Mn
Egypt
$17.0 Mn
Philippines
$15.6 Mn
Malaysia
$11.9 Mn
Hong Kong
$9.1 Mn
Thailand
$8.7 Mn
Singapore
$8.6 Mn
Kenya
$4.1 Mn
| Market size, 2025 | $3.00 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $5.69 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Material, area and end user (see all) |
| Key players | Allergan, Galderma S.A., Merz Aesthetics, Teoxane, Croma Pharma (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Dermal fillers are gels injected under the skin to restore volume, smooth lines and shape lips, cheeks and jaw.
Key segments of the dermal Fillers market include material (Hyaluronic Acid, Calcium Hydroxylapatite and Poly-L-Lactic Acid) and area (Lips, Cheeks and Nasolabial Folds).
Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the dermal Fillers market. More clinics and chains are opening in fast-growing cities.
Treatments for men, at-home options, digital consultations and growth in Asia and the Middle East give the dermal Fillers market room to grow.
Treatments are mostly paid out of pocket, results and safety vary between providers, and economic slowdowns can reduce spending on the dermal Fillers market.
The dermal Fillers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how dermal Fillers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Dermal Fillers right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Pharmaceuticals · US
Digital Health · US
Healthcare Services · US
Pharmaceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US